MEDB-30. Subclassification of Group 3/4 medulloblastoma as a potential prognostic biomarker to reduce the dose of craniospinal irradiation in patients with metastatic tumors: A Japanese Pediatric Molecular Neuro-Oncology Group study
MEDB-30. 将髓母细胞瘤3/4组进行亚分类作为潜在的预后生物标志物，以降低转移性肿瘤患者颅脊髓照射剂量：一项日本儿科分子神经肿瘤学组研究
期刊:
影响因子:
doi:10.1136/bmj.310.6985.1011
Bell, B A; Yamasaki, Fumiyuki; Mishima, Kazuhiko; Natsumeda, Manabu; Ohka, Fumiharu; Yonezawa, Hajime; Sasaki, Nobuyoshi; Yamaguchi, Shigeru; Tateishi, Kensuke; Narita, Yoshitaka; Kawai, Yasukazu; Sugahara, Hiroyuki; Kuroda, Jun-ichiro; Okuda, Takeshi; Matsutani, Tomoo; Kinoshita, Manabu; Tomita, Naoto; Hattori, Keiichiro; Muto, Jun; Kitamura, Noriaki; Higuchi, Yudai; Nagane, Motoo; Fukuoka, Kohei; Kurihara, Jun; Mori, Makiko; Arakawa, Yuki; Yoshioka, Ema; Shofuda, Tomoko; Matsushita, Yuko; Hibiya, Yuko; Honda, Satoko; Nakazawa, Atsuko; Kiyotani, Chikako; Kagawa, Naoki; Yamasaki, Kai; Ando, Ryo; Keino, Dai; Miyairi, Yosuke; Akai, Takuya; Kanamori, Masayuki; Ishida, Joji; Park, Young-Soo; Kawamura, Atsufumi; Sasaki, Atsushi; Nishikawa, Ryo; Date, Isao; Nagane, Motoo; Koh, Katsuyoshi; Ichimura, Koichi; Kanemura, Yonehiro
